rediff.com
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
Kappac Pharma Ltd. - Research Center
506938 KAPPH Group (XC) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Balance sheet
(Rs crore)
Mar ' 20 Mar ' 18 Mar ' 17 Mar ' 16 Mar ' 15
Sources of funds
Owner's fund
Equity share capital 30.27 30.27 30.27 30.27 30.27
Share application money - - - - -
Preference share capital - - - - -
Reserves & surplus 6.03 7.69 7.70 7.74 7.77
Loan funds
Secured loans - 0.20 - - -
Unsecured loans - - - - -
Total 36.29 38.16 37.96 38.01 38.03
Uses of funds
Fixed assets
Gross block - - - - -
Less : revaluation reserve - - - - -
Less : accumulated depreciation - - - - -
Net block - - - - -
Capital work-in-progress - - - - -
Investments 11.46 37.99 37.99 38.01 38.01
Net current assets
Current assets, loans & advances 24.89 0.22 0.02 0.03 0.03
Less : current liabilities & provisions 0.06 0.05 0.05 0.03 0.01
Total net current assets 24.83 0.17 -0.03 - 0.02
Miscellaneous expenses not written - - - - -
Total 36.29 38.16 37.96 38.01 38.03
Notes:
Book value of unquoted investments - - 29.31 29.31 29.70
Market value of quoted investments - - - - -
Contingent liabilities - - - - -
Number of equity sharesoutstanding (Lacs) 302.65 302.65 302.65 302.65 302.65
Close
Add Kappac Pharma Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Kappac Pharma Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close